Identification of human papillomavirus type 16 in primary and recurrent cervical cancer following radiation therapy.
Formalin-fixed, paraffin-embedded tissue blocks from 13 women with cervical carcinoma that recurred following radiation therapy were evaluated for the presence of human papillomavirus (HPV) by in situ hybridization using ribonucleic acid 35S-labeled probes for HPV types 6, 11, 16, and 18. Ten of thirteen patients also had pretreatment biopsies from their primary tumors available for analysis. HPV 16 was detected in both primary and recurrent lesions in 4 women. In 1 case, HPV was detected in the primary tumor and not in the recurrence. HPV 16 was also present in three recurrent cancers from which primary lesions were not available for probing. Radiation therapy did not alter the hybridization signal strength or pattern, suggesting that the HPV genome copy number was not significantly affected. The persistence of HPV 16 in recurrent cervical carcinoma is consistent with the theory that HPV plays a role in maintaining the malignant state.
Holloway
R W
RW
Department of Obstetrics and Gynecology, Georgetown University Hospital, Washington, D.C. 20007.
Farrell
M P
MP
Castellano
C
C
Barnes
W A
WA
Lewandowski
G
G
Jenson
B
B
Santos
C
C
Ramirez
G
G
Delgado
G
G
D000328:Adult; D001706:Biopsy; D002584:Cervix Uteri / Q000382:microbiology / Q000473:pathology; D005260:Female; D006801:Humans; D009364:Neoplasm Recurrence, Local; D009693:Nucleic Acid Hybridization; D027383:Papillomaviridae / Q000302:isolation & purification* / Q000528:radiation effects; D015347:RNA Probes; D002583:Uterine Cervical Neoplasms / Q000382:microbiology* / Q000473:pathology / Q000532:radiotherapy
D015347:RNA Probes